Glycerophospho-N-Arachidonoyl Ethanolamine – 5 mg

Brand:
Cayman
CAS:
201738-25-2
Storage:
-20
UN-No:
Non-Hazardous - /

N-Acylated ethanolamines (NAE) are naturally-occurring lipids that have diverse bioactivities. The different types of NAE can be derived from glycerophospho-linked precursors by the activity of glycerophosphodiesterase 1 (GDE1).{15460} Glycerophospho-N-arachidonoyl ethanolamine is the precursor of arachidonoyl ethanolamide (AEA), also known as anandamide. AEA is an endogenous cannabinoid neurotransmitter that binds to both central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.{2713} It inhibits the specific binding of [3H]-HU-243 to synaptosomal membranes with a Ki value of 52 nM, compared to 46 nM for Δ9-THC.{1134}  

 

Available on backorder

SKU: 10011347 - 5 mg Category:

Description

The precursor of arachidonoyl ethanolamide (AEA), also known as anandamide, an endogenous cannabinoid neurotransmitter that binds to both CB1 and CB2 receptors


Formal name: mono(2,3-dihydroxypropyl)-mono[2-[[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl]ethyl]ester phosphoric acid

Synonyms:  Glycerophospho-Arachidonoyl Ethanolamide|Glycerophosphoanandamide|GP-NArE

Molecular weight: 501.6

CAS: 201738-25-2

Purity: ≥97%

Formulation: A crystalline solid


Product Type|Biochemicals|Lipids|Fatty Amides||Product Type|Biochemicals|Lipids|Glycerophospholipids||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Lipid Biochemistry|Glycerophospholipids||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids||Research Area|Neuroscience|Pain Research